AR082270A1 - COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH - Google Patents
COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTHInfo
- Publication number
- AR082270A1 AR082270A1 ARP110101876A AR082270A1 AR 082270 A1 AR082270 A1 AR 082270A1 AR P110101876 A ARP110101876 A AR P110101876A AR 082270 A1 AR082270 A1 AR 082270A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- agents
- weight
- compositions
- oral care
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composiciones que impiden el crecimiento de las bacterias resistentes a altas concentraciones salinas, los métodos para su preparación y sus métodos de uso.Reivindicación 1: Una composición para el cuidado oral caracterizada porque incluye carbonato de calcio; alcohol bencílico; uno o más agentes de precipitación; y uno o más agentes depuradores de iones de calcio. Reivindicación 2: La composición de la reivindicación 1 caracterizada porque al menos uno de los uno o más agentes de precipitación es seleccionado a partir de silicato de sodio y pirofosfato tetrasódico. Reivindicación 3: La composición de la reivindicación 1, caracterizada porque al menos uno de los uno o más agentes depuradores de iones de calcio es seleccionado a partir de fosfato monosódico, hidrógeno fosfato disódico y bicarbonato de sodio. Reivindicación 6: La composición de la reivindicación 1, caracterizada porque además incluye uno o más agentes modificadores del pH. Reivindicación 8: La composición de la reivindicación 7, caracterizada porque al menos uno de los uno o más agentes modificadores del pH es hidróxido de sodio. Reivindicación 11: La composición de la reivindicación 1, caracterizada porque el pH se ubica entre aproximadamente 9 y alrededor de 10. Reivindicación 28: La composición de la reivindicación 27, caracterizada porque el sistema bacteriostático incluye entre aproximadamente 0,05% y alrededor de 2% en peso de pirofosfato tetrasódico; entre aproximadamente 0,05% y alrededor de 2% en peso de bicarbonato de sodio; entre aproximadamente 0,2% y alrededor de 0,5% en peso de alcohol bencílico; y entre aproximadamente 0,05% y alrededor de 0,2% en peso de hidróxido de sodio. Reivindicación 37: La composición de la reivindicación 1, caracterizada porque además incluye bicarbonato de L-arginina.Compositions that prevent the growth of bacteria resistant to high salt concentrations, the methods for their preparation and their methods of use. Claim 1: An oral care composition characterized in that it includes calcium carbonate; benzyl alcohol; one or more precipitation agents; and one or more calcium ion purifying agents. Claim 2: The composition of claim 1 characterized in that at least one of the one or more precipitating agents is selected from sodium silicate and tetrasodium pyrophosphate. Claim 3: The composition of claim 1, characterized in that at least one of the one or more calcium ion scavenging agents is selected from monosodium phosphate, disodium hydrogen phosphate and sodium bicarbonate. Claim 6: The composition of claim 1, characterized in that it also includes one or more pH modifying agents. Claim 8: The composition of claim 7, characterized in that at least one of the one or more pH modifying agents is sodium hydroxide. Claim 11: The composition of claim 1, characterized in that the pH is between about 9 and about 10. Claim 28: The composition of claim 27, characterized in that the bacteriostatic system includes between about 0.05% and about 2 % by weight of tetrasodium pyrophosphate; between about 0.05% and about 2% by weight of sodium bicarbonate; between about 0.2% and about 0.5% by weight of benzyl alcohol; and between about 0.05% and about 0.2% by weight of sodium hydroxide. Claim 37: The composition of claim 1, characterized in that it further includes L-arginine bicarbonate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP110101876 AR082270A1 (en) | 2011-05-31 | 2011-05-31 | COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP110101876 AR082270A1 (en) | 2011-05-31 | 2011-05-31 | COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH |
Publications (1)
Publication Number | Publication Date |
---|---|
AR082270A1 true AR082270A1 (en) | 2012-11-28 |
Family
ID=47562006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110101876 AR082270A1 (en) | 2011-05-31 | 2011-05-31 | COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR082270A1 (en) |
-
2011
- 2011-05-31 AR ARP110101876 patent/AR082270A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012027179A2 (en) | microbial growth resistant oral hygiene compositions | |
RS53994B1 (en) | Micronized caco3 slurry injection system for the remineralization of desalinated and fresh water | |
ES2525721T3 (en) | Composition that has biocidal activity for aqueous preparations | |
CY1118189T1 (en) | ENLARGEMENT OF SALT WATER AND GLUT WATER BY ADMINISTRATION OF A SOIL CALCIUM SOLUTION IN SOFT WATER | |
CO6190603A2 (en) | ACID 7- (2-METHYLPIRIDIN-3-IL CARBOMOIL) -4A-BENZIL-2- (TRIFLUOROMETIL) -1,2,3,4,4A, 9, 10, 10A-OCTAHIDRO FENANTREN-2-IL-2-PHOSPHONIC AS GLUCOCORTICOID RECEPTOR MODULATORS | |
RU2015126801A (en) | FLUORIDE-STABLE ZINC-CONTAINING COMPOSITIONS FOR CARE OF THE ORAL CAVITY | |
CL2013003000A1 (en) | Pharmaceutical composition for oral care, comprising a calcium salt and a source of soluble phosphate; method to whiten and remineralize teeth; and use of said composition in remineralization, decreased sensitivity and / or teeth whitening and combinations thereof. | |
CL2012000079A1 (en) | Process for the reduction of magnesium in a brine, which comprises adjusting the brine to a lithium content of 4.5 to 6% by weight, adding kcl solution to precipitate carnalite, and further concentrating and precipitating magnesium as carnalite; lithium carbonate; and lithium chloride. | |
AR084863A1 (en) | INHIBITORS OF GIRASA AND TOPOISOMERASE IV USEFUL TO TREAT BACTERIAL INFECTIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MX336343B (en) | Compositions and methods for improving the compatibility of water soluble herbicide salts. | |
AR065963A1 (en) | WATER SOLUTION OF HYDROGEN PEROXIDE, PROCESS FOR PREPARATION AND USE | |
BRPI0416360A (en) | process for the cultivation of thraustochytriales microorganisms using a low-optimized medium | |
GT201400027A (en) | Aqueous CONCENTRATED SUSPENSION THAT INCLUDES AN ACID DODECILGUANIDINE SALT | |
BR112013001743A2 (en) | biocidal composition, and method for controlling growth of microorganisms in an aqueous or water-containing system. | |
BR112014000547A2 (en) | deoxycholic acid formulations and salts thereof | |
BR112012026659A2 (en) | surface disinfecting compound. | |
AR089269A1 (en) | COMPOSITIONS FOR ORAL CARE | |
ES2509966T1 (en) | Compositions having increased concentrations of carboxymethyl cellulose | |
AR088067A1 (en) | METHOD FOR REDUCING TRANSPIRATION AND ANTITRANSPIRANT COMPOSITIONS | |
AR083443A1 (en) | A COMPOSITION THAT INCLUDES BACTERIAL ARN AND BACTERIAL CELL WALLS, METHOD FOR PREPARING SUCH COMPOSITION AND ITS USES | |
AR084580A1 (en) | ORAL LIQUID CARE COMPOSITIONS | |
BR112014012762A2 (en) | reduced wound healing system | |
AR087371A1 (en) | FORMULATIONS OF (TRIMETOXIFENILAMINO) PYRIMIDINYL, METHODS | |
PE20130374A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING IBUPROFEN | |
AR082270A1 (en) | COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |